Unibios Holdings Statistics
Total Valuation
ATH:BIOSK has a market cap or net worth of EUR 35.73 million. The enterprise value is 44.81 million.
| Market Cap | 35.73M |
| Enterprise Value | 44.81M |
Important Dates
The next estimated earnings date is Tuesday, December 29, 2026.
| Earnings Date | Dec 29, 2026 |
| Ex-Dividend Date | Dec 10, 2026 |
Share Statistics
ATH:BIOSK has 17.43 million shares outstanding. The number of shares has increased by 13.62% in one year.
| Current Share Class | 17.43M |
| Shares Outstanding | 17.43M |
| Shares Change (YoY) | +13.62% |
| Shares Change (QoQ) | -19.23% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 283.74.
| PE Ratio | 283.74 |
| Forward PE | n/a |
| PS Ratio | 2.33 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 3.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 314.29 |
| EV / Sales | 2.93 |
| EV / EBITDA | 35.62 |
| EV / EBIT | 74.81 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.96, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.96 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 6.34 |
| Debt / FCF | n/a |
| Interest Coverage | 1.80 |
Financial Efficiency
Return on equity (ROE) is -0.17% and return on invested capital (ROIC) is -0.16%.
| Return on Equity (ROE) | -0.17% |
| Return on Assets (ROA) | 1.14% |
| Return on Invested Capital (ROIC) | -0.16% |
| Return on Capital Employed (ROCE) | 2.26% |
| Weighted Average Cost of Capital (WACC) | 5.14% |
| Revenue Per Employee | 153,181 |
| Profits Per Employee | 1,429 |
| Employee Count | 99 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, ATH:BIOSK has paid 501,906 in taxes.
| Income Tax | 501,906 |
| Effective Tax Rate | 107.57% |
Stock Price Statistics
The stock price has decreased by -35.69% in the last 52 weeks. The beta is 0.38, so ATH:BIOSK's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -35.69% |
| 50-Day Moving Average | 2.40 |
| 200-Day Moving Average | 2.57 |
| Relative Strength Index (RSI) | 31.45 |
| Average Volume (20 Days) | 15,248 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ATH:BIOSK had revenue of EUR 15.16 million and earned 141,467 in profits. Earnings per share was 0.01.
| Revenue | 15.16M |
| Gross Profit | 6.20M |
| Operating Income | 594,309 |
| Pretax Income | 466,575 |
| Net Income | 141,467 |
| EBITDA | 1.03M |
| EBIT | 594,309 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 1.16 million in cash and 7.92 million in debt, with a net cash position of -6.75 million or -0.39 per share.
| Cash & Cash Equivalents | 1.16M |
| Total Debt | 7.92M |
| Net Cash | -6.75M |
| Net Cash Per Share | -0.39 |
| Equity (Book Value) | 21.89M |
| Book Value Per Share | 1.12 |
| Working Capital | 8.42M |
Cash Flow
In the last 12 months, operating cash flow was -1.88 million and capital expenditures -2.76 million, giving a free cash flow of -4.64 million.
| Operating Cash Flow | -1.88M |
| Capital Expenditures | -2.76M |
| Depreciation & Amortization | 434,584 |
| Net Borrowing | -681,106 |
| Free Cash Flow | -4.64M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 40.87%, with operating and profit margins of 3.92% and 0.93%.
| Gross Margin | 40.87% |
| Operating Margin | 3.92% |
| Pretax Margin | 3.08% |
| Profit Margin | 0.93% |
| EBITDA Margin | 6.78% |
| EBIT Margin | 3.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.22%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 1.22% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 346.02% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -13.62% |
| Shareholder Yield | -12.40% |
| Earnings Yield | 0.35% |
| FCF Yield | -13.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 10, 2017. It was a reverse split with a ratio of 0.2.
| Last Split Date | Feb 10, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
ATH:BIOSK has an Altman Z-Score of 3.24 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.24 |
| Piotroski F-Score | 3 |